No full text
Poster (Scientific congresses and symposiums)
A case of hemolytic anemia after severe malaria successfully treated with artesunate
ROUYA, Laura; LEONARD, Philippe; Hayette, Marie-Pierre
2013Joined symposium BVIKM-SBIMC-Scientific Study group for travel medecine
 

Files


Full Text
No document available.

Send to



Details



Keywords :
Plasmodium falciparum; hemolytic anemia; artesunate; malaria
Abstract :
[en] Intravenous artesunate is the treatment of choice for severe and complicated malaria according to the WHO 2010 guidelines. Seventeencases of delayed hemolysis after parenteral treatment with artesunate have been recently reported in European travellers with imported Plasmodium falciparummalaria1. We report the case of a 40-years-old Belgian man who contracted severe falciparum malaria after a four-weeks stay in Central and Eastern Africa without taking any antimalarial chemoprophylaxis. He presented on admission with fever, headache, jaundice andabdominal syndrome.Thereafter hisbiological and clinical conditionrapidly worsened withconsciousness disorders, severe thrombocytopenia,acute hepatitis and pancreatitis, and renal failure. Parasitemia reached a peak of 37 % on the second day of admission. Since this patient fulfilled WHO 2010 criteria for severe malaria,intravenous artesunatetreatment dosed at 2,4 mg/kg was started. Parasite clearancewas obtained after 48 hours and the patient’s clinical status improved significantly.Five doses of intravenous artesunate were administered, followed by oral artemeter/lumefantrine treatment during 60 hours. Tendays after the first dose of artesunate the patient developed a severe hemolyticanemia(hemoglobin4,9 g/dL) associated with impaired renal function. Thick blood film was negative. Blood transfusion and high doses of corticosteroids were successfully administrated and hemodialysis was not necessary. Until now, no clear explanation has been given to this complication. This case highlights the usefulness of extended follow-up including haematological parametersforpatients treated with artesunate, at least one monthafter the malaria episode. 1Published reports of delayed hemolyticanemia after treatment with artesunate for severe malaria--worldwide, 2010-2012. Centers for Disease Control and Prevention (CDC).
Disciplines :
Immunology & infectious disease
Author, co-author :
ROUYA, Laura ;  Centre Hospitalier Universitaire de Liège - CHU > Frais communs Biologie Clinique
LEONARD, Philippe ;  Centre Hospitalier Universitaire de Liège - CHU > Maladies infectieuses et médecine interne générale
Hayette, Marie-Pierre  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Bactériologie, mycologie, parasitologie, virologie
Language :
English
Title :
A case of hemolytic anemia after severe malaria successfully treated with artesunate
Alternative titles :
[fr] Anémie hémolytique sévère survenue après traitement d'un accès palustre par artesunate
Publication date :
24 October 2013
Event name :
Joined symposium BVIKM-SBIMC-Scientific Study group for travel medecine
Event organizer :
BVIKM-TRAVEL MEDECINE SOCIETY
Event place :
ANTWERPEN, Belgium
Event date :
24-10-2013
Available on ORBi :
since 25 January 2014

Statistics


Number of views
181 (6 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi